DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: c-Myc alters substrate utilization and O-GlcNAc protein posttranslational modifications without altering cardiac function during early aortic constriction

Abstract

Pressure overload cardiac hypertrophy alters substrate metabolism. Prior work showed that myocardial inactivation of c-Myc (Myc) attenuated hypertrophy and decreased expression of metabolic genes after aortic constriction. Accordingly, we hypothesize that Myc regulates substrate preferences for the citric acid cycle during pressure overload hypertrophy from transverse aortic constriction (TAC) and that these metabolic changes impact cardiac function and growth. To test this hypothesis, we subjected mice with cardiac specific, inducible Myc inactivation (MycKO-TAC) and non-transgenic littermates (Cont-TAC) to transverse aortic constriction (TAC; n=7/group). A separate group underwent sham surgery (Sham, n=5). After two weeks, function was measured in isolated working hearts along with substrate fractional contributions to the citric acid cycle by using perfusate with 13C labeled mixed fatty acids, lactate, ketone bodies and unlabeled glucose and insulin. Cardiac function was similar between groups after TAC although +dP/dT and -dP/dT trended towards improvement in MycKO-TAC versus Cont-TAC. Compared to Sham, Cont-TAC had increased free fatty acid fractional contribution with a concurrent decrease in unlabeled (predominately glucose) contribution. The changes in free fatty acid and unlabeled fractional contributions were abrogated by Myc inactivation during TAC (MycKO-TAC). Additionally, protein posttranslational modification by O-GlcNAc was significantly greater in Cont-TAC versus both Sham andmore » MycKO-TAC. Lastly, Myc alters substrate preferences for the citric acid cycle during early pressure overload hypertrophy without negatively affecting cardiac function. Myc also affects protein posttranslational modifications by O-GlcNAc during hypertrophy.« less

Authors:
 [1];  [2];  [1];  [1];  [3];  [4];  [4];  [5]
  1. Seattle Children's Research Institute, Seattle, WA (United States)
  2. Univ. of Washington, Seattle, WA (United States)
  3. Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
  4. Seattle Children's Research Institute, Seattle, WA (United States); Univ. of Washington, Seattle, WA (United States)
  5. Univ. Catholique de Louvain (Belgium)
Publication Date:
Research Org.:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER)
OSTI Identifier:
1229960
Report Number(s):
PNNL-SA-106577
Journal ID: ISSN 1932-6203; 48162; 600306000
Grant/Contract Number:  
AC05-76RL01830
Resource Type:
Accepted Manuscript
Journal Name:
PLoS ONE
Additional Journal Information:
Journal Volume: 10; Journal Issue: 8; Journal ID: ISSN 1932-6203
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Environmental Molecular Sciences Laboratory; heart; fatty acids; glucose metabolism; citric acid cycle; glucose; protein metabolism; enzyme metabolism; oxidation

Citation Formats

Ledee, Dolena, Smith, Lincoln, Bruce, Margaret, Kajimoto, Masaki, Isern, Nancy, Portman, Michael A., Olson, Aaron K., and Bertrand, Luc. c-Myc alters substrate utilization and O-GlcNAc protein posttranslational modifications without altering cardiac function during early aortic constriction. United States: N. p., 2015. Web. doi:10.1371/journal.pone.0135262.
Ledee, Dolena, Smith, Lincoln, Bruce, Margaret, Kajimoto, Masaki, Isern, Nancy, Portman, Michael A., Olson, Aaron K., & Bertrand, Luc. c-Myc alters substrate utilization and O-GlcNAc protein posttranslational modifications without altering cardiac function during early aortic constriction. United States. https://doi.org/10.1371/journal.pone.0135262
Ledee, Dolena, Smith, Lincoln, Bruce, Margaret, Kajimoto, Masaki, Isern, Nancy, Portman, Michael A., Olson, Aaron K., and Bertrand, Luc. Wed . "c-Myc alters substrate utilization and O-GlcNAc protein posttranslational modifications without altering cardiac function during early aortic constriction". United States. https://doi.org/10.1371/journal.pone.0135262. https://www.osti.gov/servlets/purl/1229960.
@article{osti_1229960,
title = {c-Myc alters substrate utilization and O-GlcNAc protein posttranslational modifications without altering cardiac function during early aortic constriction},
author = {Ledee, Dolena and Smith, Lincoln and Bruce, Margaret and Kajimoto, Masaki and Isern, Nancy and Portman, Michael A. and Olson, Aaron K. and Bertrand, Luc},
abstractNote = {Pressure overload cardiac hypertrophy alters substrate metabolism. Prior work showed that myocardial inactivation of c-Myc (Myc) attenuated hypertrophy and decreased expression of metabolic genes after aortic constriction. Accordingly, we hypothesize that Myc regulates substrate preferences for the citric acid cycle during pressure overload hypertrophy from transverse aortic constriction (TAC) and that these metabolic changes impact cardiac function and growth. To test this hypothesis, we subjected mice with cardiac specific, inducible Myc inactivation (MycKO-TAC) and non-transgenic littermates (Cont-TAC) to transverse aortic constriction (TAC; n=7/group). A separate group underwent sham surgery (Sham, n=5). After two weeks, function was measured in isolated working hearts along with substrate fractional contributions to the citric acid cycle by using perfusate with 13C labeled mixed fatty acids, lactate, ketone bodies and unlabeled glucose and insulin. Cardiac function was similar between groups after TAC although +dP/dT and -dP/dT trended towards improvement in MycKO-TAC versus Cont-TAC. Compared to Sham, Cont-TAC had increased free fatty acid fractional contribution with a concurrent decrease in unlabeled (predominately glucose) contribution. The changes in free fatty acid and unlabeled fractional contributions were abrogated by Myc inactivation during TAC (MycKO-TAC). Additionally, protein posttranslational modification by O-GlcNAc was significantly greater in Cont-TAC versus both Sham and MycKO-TAC. Lastly, Myc alters substrate preferences for the citric acid cycle during early pressure overload hypertrophy without negatively affecting cardiac function. Myc also affects protein posttranslational modifications by O-GlcNAc during hypertrophy.},
doi = {10.1371/journal.pone.0135262},
journal = {PLoS ONE},
number = 8,
volume = 10,
place = {United States},
year = {Wed Aug 12 00:00:00 EDT 2015},
month = {Wed Aug 12 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 18 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression.
journal, November 1986

  • Starksen, N. F.; Simpson, P. C.; Bishopric, N.
  • Proceedings of the National Academy of Sciences, Vol. 83, Issue 21
  • DOI: 10.1073/pnas.83.21.8348

Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression.
journal, November 1986

  • Starksen, N. F.; Simpson, P. C.; Bishopric, N.
  • Proceedings of the National Academy of Sciences, Vol. 83, Issue 21
  • DOI: 10.1073/pnas.83.21.8348

Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
journal, August 2013


Regulation of a Cytosolic and Nuclear O -GlcNAc Transferase : ROLE OF THE TETRATRICOPEPTIDE REPEATS
journal, November 1999


Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload Hypertrophy
journal, August 2012


Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy and Reactivation of DNA Synthesis
journal, December 2001

  • Xiao, Guishan; Mao, Songyan; Baumgarten, Georg
  • Circulation Research, Vol. 89, Issue 12
  • DOI: 10.1161/hh2401.100742

Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy
journal, July 2013

  • Gao, Z.; Cooper, T. A.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 33
  • DOI: 10.1073/pnas.1308806110

GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure
journal, July 2014

  • Pereira, Renata O.; Wende, Adam R.; Olsen, Curtis
  • Journal of Molecular and Cellular Cardiology, Vol. 72
  • DOI: 10.1016/j.yjmcc.2014.02.011

Inducible Overexpression of GLUT1 Prevents Mitochondrial Dysfunction and Attenuates Structural Remodeling in Pressure Overload but Does Not Prevent Left Ventricular Dysfunction
journal, September 2013

  • Pereira, Renata O.; Wende, Adam R.; Olsen, Curtis
  • Journal of the American Heart Association, Vol. 2, Issue 5
  • DOI: 10.1161/JAHA.113.000301

Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload
journal, February 2004


Targeting myocardial substrate metabolism in heart failure: potential for new therapies
journal, February 2012

  • Ardehali, Hossein; Sabbah, Hani N.; Burke, Michael A.
  • European Journal of Heart Failure, Vol. 14, Issue 2
  • DOI: 10.1093/eurjhf/hfr173

Myocardial Substrate Metabolism in the Normal and Failing Heart
journal, July 2005

  • Stanley, William C.; Recchia, Fabio A.; Lopaschuk, Gary D.
  • Physiological Reviews, Vol. 85, Issue 3
  • DOI: 10.1152/physrev.00006.2004

Studies on l-Glutamine d-Fructose 6-Phosphate Amidotransferase
journal, July 1967


Transverse Aortic Constriction in Mice
journal, April 2010

  • deAlmeida, Angela C.; van Oort, Ralph J.; Wehrens, Xander H. T.
  • Journal of Visualized Experiments, Issue 38
  • DOI: 10.3791/1729-v

Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production
journal, August 2013


A PKM2 signature in the failing heart
journal, April 2015

  • Rees, Meredith L.; Subramaniam, Janani; Li, Yuanteng
  • Biochemical and Biophysical Research Communications, Vol. 459, Issue 3
  • DOI: 10.1016/j.bbrc.2015.02.122

Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
journal, January 1988

  • Izumo, S.; Nadal-Ginard, B.; Mahdavi, V.
  • Proceedings of the National Academy of Sciences, Vol. 85, Issue 2
  • DOI: 10.1073/pnas.85.2.339

Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload
journal, December 2012

  • Zhabyeyev, Pavel; Gandhi, Manoj; Mori, Jun
  • Cardiovascular Research, Vol. 97, Issue 4
  • DOI: 10.1093/cvr/cvs424

C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle
journal, February 2013


Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models
journal, July 2009


Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation
journal, April 2011


Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice
journal, May 2010

  • Ahuja, Preeti; Zhao, Peng; Angelis, Ekaterini
  • Journal of Clinical Investigation, Vol. 120, Issue 5
  • DOI: 10.1172/JCI38331

Protein O-linked β-N-acetylglucosamine: A novel effector of cardiomyocyte metabolism and function
journal, March 2012

  • Darley-Usmar, Victor M.; Ball, Lauren E.; Chatham, John C.
  • Journal of Molecular and Cellular Cardiology, Vol. 52, Issue 3
  • DOI: 10.1016/j.yjmcc.2011.08.009

Contribution of various substrates to total citric acid cycle flux and ]anaplerosis as determined by13C isotopomer analysis and O2 consumption in the heart
journal, March 1996

  • Malloy, Craig R.; Jones, John G.; Jeffrey, F. Mark
  • MAGMA Magnetic Resonance Materials in Physics, Biology, and Medicine, Vol. 4, Issue 1
  • DOI: 10.1007/BF01759778

PGC-1β Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy
journal, September 2011


Metabolic Remodeling in the Hypertrophic Heart
journal, August 2012


Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure
journal, September 2009


Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
journal, January 1988

  • Izumo, S.; Nadal-Ginard, B.; Mahdavi, V.
  • Proceedings of the National Academy of Sciences, Vol. 85, Issue 2
  • DOI: 10.1073/pnas.85.2.339

Triidothyronine and epinephrine rapidly modify myocardial substrate selection: a 13 C isotopomer analysis
journal, November 2001

  • Krueger, Julia J.; Ning, Xue-Han; Argo, Barisa M.
  • American Journal of Physiology-Endocrinology and Metabolism, Vol. 281, Issue 5
  • DOI: 10.1152/ajpendo.2001.281.5.E983

Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy and Reactivation of DNA Synthesis
journal, December 2001

  • Xiao, Guishan; Mao, Songyan; Baumgarten, Georg
  • Circulation Research, Vol. 89, Issue 12
  • DOI: 10.1161/hh2401.100742

Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway
journal, August 2006


The Failing Heart — An Engine Out of Fuel
journal, March 2007


Change of c-Myc expression and cardiac hypertrophy in patients with aortic valve replacement
journal, April 2001


Pyruvate kinase type M2 and its role in tumor growth and spreading
journal, August 2005


HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
journal, December 2009

  • David, Charles J.; Chen, Mo; Assanah, Marcela
  • Nature, Vol. 463, Issue 7279
  • DOI: 10.1038/nature08697

Works referencing / citing this record:

The role of post‐translational modifications in cardiac hypertrophy
journal, April 2019

  • Yan, Kaowen; Wang, Kun; Li, Peifeng
  • Journal of Cellular and Molecular Medicine, Vol. 23, Issue 6
  • DOI: 10.1111/jcmm.14330

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
journal, June 2019

  • Tran, Diem H.; Wang, Zhao V.
  • Journal of the American Heart Association, Vol. 8, Issue 12
  • DOI: 10.1161/jaha.119.012673

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
journal, January 2018


O‐GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O‐GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload
journal, June 2019

  • Zhu, Wei‐Zhong; El‐Nachef, Danny; Yang, Xiulan
  • Journal of the American Heart Association, Vol. 8, Issue 11
  • DOI: 10.1161/jaha.118.011260

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
journal, January 2018


O-GlcNAcylation and cardiovascular disease
journal, April 2017

  • Wright, JaLessa N.; Collins, Helen E.; Wende, Adam R.
  • Biochemical Society Transactions, Vol. 45, Issue 2
  • DOI: 10.1042/bst20160164

The role of post‐translational modifications in cardiac hypertrophy
journal, April 2019

  • Yan, Kaowen; Wang, Kun; Li, Peifeng
  • Journal of Cellular and Molecular Medicine, Vol. 23, Issue 6
  • DOI: 10.1111/jcmm.14330

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
journal, June 2019

  • Tran, Diem H.; Wang, Zhao V.
  • Journal of the American Heart Association, Vol. 8, Issue 12
  • DOI: 10.1161/jaha.119.012673